PAIN2.0: study protocol for a multicentre randomised controlled trial to evaluate the efficacy of a 10-week outpatient interdisciplinary multimodal pain therapy to manage recurrent pain for patients with risk factors of developing chronic pain in Germany
Abstract Background Up to 27% of the German population suffers from recurrent or persistent pain (lasting more than three months). Therefore, prevention of chronic pain is one major object of pain management interventions. The aim of this nationwide, multicentre, randomised controlled trial is to ev...
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-02-01
|
| Series: | Trials |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13063-024-07975-4 |
| _version_ | 1797273396373880832 |
|---|---|
| author | Sandra Meyer-Moock Daniel Szczotkowski Leonie Schouten Frank Petzke Lena Milch Beatrice Metz-Oster Louise Zinndorf Christian Geber Greta Hoffmann Anke Preißler Ursula Marschall Felix Rottke Anja Waidner André Möller Thomas Isenberg Gabriele Lindena Anne Gärtner Ulrike Kaiser Thomas Kohlmann |
| author_facet | Sandra Meyer-Moock Daniel Szczotkowski Leonie Schouten Frank Petzke Lena Milch Beatrice Metz-Oster Louise Zinndorf Christian Geber Greta Hoffmann Anke Preißler Ursula Marschall Felix Rottke Anja Waidner André Möller Thomas Isenberg Gabriele Lindena Anne Gärtner Ulrike Kaiser Thomas Kohlmann |
| author_sort | Sandra Meyer-Moock |
| collection | DOAJ |
| description | Abstract Background Up to 27% of the German population suffers from recurrent or persistent pain (lasting more than three months). Therefore, prevention of chronic pain is one major object of pain management interventions. The aim of this nationwide, multicentre, randomised controlled trial is to evaluate the efficacy of a 10-week ambulatory (outpatient) interdisciplinary multimodal pain therapy (A-IMPT) for patients with recurrent pain and at risk of developing chronic pain. This project was initiated by the German Pain Society (Deutsche Schmerzgesellschaft e.V.) and the public health insurance provider BARMER. It is currently funded by the German Innovation Fund (01NVF20023). The study PAIN2.0 focuses on reducing pain intensity and pain-related disability and investigates whether this intervention can improve physical activity, psychological well-being, and health literacy. Methods PAIN2.0 is designed as a multicentre 1:1 randomised controlled trial with two parallel groups (randomisation at the patient level, planned N = 1094, duration of study participation 12 months, implemented by 22 health care facilities nationwide). After 6 months, patients within the control group also receive the intervention. The primary outcomes are pain intensity and pain-related impairment, measured as Characteristic Pain Intensity (PI) and Disability Score (DS) (Von Korff), as well as patient-related satisfaction with the intervention. Secondary outcomes are the number of sick leave days, sickness allowance, treatment costs, psychological distress, health-related quality of life, and catastrophizing. The effects of the intervention will be analysed by a parallel-group comparison between the intervention and control groups. In addition, the long-term effects within the intervention group will be observed and a pre-post comparison of the control group before and after the intervention will be performed. Discussion Recurrent or persistent pain is common in the German population and causes high costs for patients and society. The A-IMPT aims to improve pain and pain-related impairments in pain patients at risk of chronification, thereby reducing the risk of developing chronic pain with its high socioeconomic burden. This new therapy could easily be integrated into existing therapy programs if positively evaluated. Trial registration The trial PAIN2.0 has been registered in the German Clinical Trials Register (DRKS) since 21/11/2022 with the ID DRKS00030773 . |
| first_indexed | 2024-03-07T14:42:47Z |
| format | Article |
| id | doaj.art-84d44fb0f6904d51939d606d7d314f5c |
| institution | Directory Open Access Journal |
| issn | 1745-6215 |
| language | English |
| last_indexed | 2024-03-07T14:42:47Z |
| publishDate | 2024-02-01 |
| publisher | BMC |
| record_format | Article |
| series | Trials |
| spelling | doaj.art-84d44fb0f6904d51939d606d7d314f5c2024-03-05T20:10:29ZengBMCTrials1745-62152024-02-0125111910.1186/s13063-024-07975-4PAIN2.0: study protocol for a multicentre randomised controlled trial to evaluate the efficacy of a 10-week outpatient interdisciplinary multimodal pain therapy to manage recurrent pain for patients with risk factors of developing chronic pain in GermanySandra Meyer-Moock0Daniel Szczotkowski1Leonie Schouten2Frank Petzke3Lena Milch4Beatrice Metz-Oster5Louise Zinndorf6Christian Geber7Greta Hoffmann8Anke Preißler9Ursula Marschall10Felix Rottke11Anja Waidner12André Möller13Thomas Isenberg14Gabriele Lindena15Anne Gärtner16Ulrike Kaiser17Thomas Kohlmann18Institute for Community Medicine, University Medicine GreifswaldInstitute for Community Medicine, University Medicine GreifswaldDepartment of Anaesthesiology, University Medical Centre GöttingenDepartment of Anaesthesiology, University Medical Centre GöttingenGerman Red Cross Pain Centre MainzGerman Red Cross Pain Centre MainzGerman Red Cross Pain Centre MainzGerman Red Cross Pain Centre MainzUniversity Pain Centre, University Hospital Carl Gustav CarusUniversity Pain Centre, University Hospital Carl Gustav CarusBARMERGerman Pain SocietyGerman Pain SocietyGerman Pain SocietyGerman Pain SocietyCLARA Klinische Und VersorgungsforschungUniversity Pain Centre, University Hospital Carl Gustav CarusUniversity Hospital Schleswig-Holstein/LübeckInstitute for Community Medicine, University Medicine GreifswaldAbstract Background Up to 27% of the German population suffers from recurrent or persistent pain (lasting more than three months). Therefore, prevention of chronic pain is one major object of pain management interventions. The aim of this nationwide, multicentre, randomised controlled trial is to evaluate the efficacy of a 10-week ambulatory (outpatient) interdisciplinary multimodal pain therapy (A-IMPT) for patients with recurrent pain and at risk of developing chronic pain. This project was initiated by the German Pain Society (Deutsche Schmerzgesellschaft e.V.) and the public health insurance provider BARMER. It is currently funded by the German Innovation Fund (01NVF20023). The study PAIN2.0 focuses on reducing pain intensity and pain-related disability and investigates whether this intervention can improve physical activity, psychological well-being, and health literacy. Methods PAIN2.0 is designed as a multicentre 1:1 randomised controlled trial with two parallel groups (randomisation at the patient level, planned N = 1094, duration of study participation 12 months, implemented by 22 health care facilities nationwide). After 6 months, patients within the control group also receive the intervention. The primary outcomes are pain intensity and pain-related impairment, measured as Characteristic Pain Intensity (PI) and Disability Score (DS) (Von Korff), as well as patient-related satisfaction with the intervention. Secondary outcomes are the number of sick leave days, sickness allowance, treatment costs, psychological distress, health-related quality of life, and catastrophizing. The effects of the intervention will be analysed by a parallel-group comparison between the intervention and control groups. In addition, the long-term effects within the intervention group will be observed and a pre-post comparison of the control group before and after the intervention will be performed. Discussion Recurrent or persistent pain is common in the German population and causes high costs for patients and society. The A-IMPT aims to improve pain and pain-related impairments in pain patients at risk of chronification, thereby reducing the risk of developing chronic pain with its high socioeconomic burden. This new therapy could easily be integrated into existing therapy programs if positively evaluated. Trial registration The trial PAIN2.0 has been registered in the German Clinical Trials Register (DRKS) since 21/11/2022 with the ID DRKS00030773 .https://doi.org/10.1186/s13063-024-07975-4Recurrent painComplex interventionPain and risk factorsOutpatient group therapyMultimodal interdisciplinary pain managementPublic health |
| spellingShingle | Sandra Meyer-Moock Daniel Szczotkowski Leonie Schouten Frank Petzke Lena Milch Beatrice Metz-Oster Louise Zinndorf Christian Geber Greta Hoffmann Anke Preißler Ursula Marschall Felix Rottke Anja Waidner André Möller Thomas Isenberg Gabriele Lindena Anne Gärtner Ulrike Kaiser Thomas Kohlmann PAIN2.0: study protocol for a multicentre randomised controlled trial to evaluate the efficacy of a 10-week outpatient interdisciplinary multimodal pain therapy to manage recurrent pain for patients with risk factors of developing chronic pain in Germany Trials Recurrent pain Complex intervention Pain and risk factors Outpatient group therapy Multimodal interdisciplinary pain management Public health |
| title | PAIN2.0: study protocol for a multicentre randomised controlled trial to evaluate the efficacy of a 10-week outpatient interdisciplinary multimodal pain therapy to manage recurrent pain for patients with risk factors of developing chronic pain in Germany |
| title_full | PAIN2.0: study protocol for a multicentre randomised controlled trial to evaluate the efficacy of a 10-week outpatient interdisciplinary multimodal pain therapy to manage recurrent pain for patients with risk factors of developing chronic pain in Germany |
| title_fullStr | PAIN2.0: study protocol for a multicentre randomised controlled trial to evaluate the efficacy of a 10-week outpatient interdisciplinary multimodal pain therapy to manage recurrent pain for patients with risk factors of developing chronic pain in Germany |
| title_full_unstemmed | PAIN2.0: study protocol for a multicentre randomised controlled trial to evaluate the efficacy of a 10-week outpatient interdisciplinary multimodal pain therapy to manage recurrent pain for patients with risk factors of developing chronic pain in Germany |
| title_short | PAIN2.0: study protocol for a multicentre randomised controlled trial to evaluate the efficacy of a 10-week outpatient interdisciplinary multimodal pain therapy to manage recurrent pain for patients with risk factors of developing chronic pain in Germany |
| title_sort | pain2 0 study protocol for a multicentre randomised controlled trial to evaluate the efficacy of a 10 week outpatient interdisciplinary multimodal pain therapy to manage recurrent pain for patients with risk factors of developing chronic pain in germany |
| topic | Recurrent pain Complex intervention Pain and risk factors Outpatient group therapy Multimodal interdisciplinary pain management Public health |
| url | https://doi.org/10.1186/s13063-024-07975-4 |
| work_keys_str_mv | AT sandrameyermoock pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT danielszczotkowski pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT leonieschouten pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT frankpetzke pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT lenamilch pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT beatricemetzoster pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT louisezinndorf pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT christiangeber pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT gretahoffmann pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT ankepreißler pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT ursulamarschall pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT felixrottke pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT anjawaidner pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT andremoller pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT thomasisenberg pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT gabrielelindena pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT annegartner pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT ulrikekaiser pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany AT thomaskohlmann pain20studyprotocolforamulticentrerandomisedcontrolledtrialtoevaluatetheefficacyofa10weekoutpatientinterdisciplinarymultimodalpaintherapytomanagerecurrentpainforpatientswithriskfactorsofdevelopingchronicpainingermany |